Hi [[ session.user.profile.firstName ]]

Medical Research

  • Close More Business with DocuSign + Box Close More Business with DocuSign + Box DocuSign and Box Aug 25 2016 9:00 pm UTC 45 mins
    The need to securely share your files quickly and easily while knowing what's going on with your business is extremely important. DocuSign's integration with Box allows you to select documents from Box you want to sign or send for signature and prepare it in just a few clicks. Completed documents automatically save back to Box and can be accessed from anywhere, on any device.

    Join this webinar to learn:
    - How to securely share files quickly
    - How to be more productive regardless of what device or application you're using.
    - How Salesforce automatically creates a workflow process with Box and DocuSign

    See how the DocuSign and Box integration can help you improve contract processes, keep all documents digital and help you get business done in 2016.
  • Accelerate Sales Productivity & Close More Deals with Salesforce + DocuSign Accelerate Sales Productivity & Close More Deals with Salesforce + DocuSign Ashley Smith, SR AE, DocuSign, Harel Shaked, Technical Project Manager, Outbrain Aug 30 2016 8:00 pm UTC 30 mins
    Fully integrated with Salesforce, DocuSign helps users close more deals, faster. Your customers can sign contracts within minutes from anywhere, anytime and on any device. Sending a contract for electronic signature from Salesforce is simple: just click “Send with DocuSign” from any object. You can even generate and send contracts synced with data from Salesforce. When you automate time-consuming manual workflows, you eliminate rekeying of data and increase your productivity.

    Join DocuSign and Outbrain, the global leader in content marketing, for a compelling webinar presentation and discussion.

    This webinar will feature guest speaker Harel Shaked, Technical Project Manager at Outbrain. He will review how Outbrain:
    - Improved sales productivity “with the click of a button” to send and sign contracts and agreements
    - Began closing deals within minutes from the time an order is sent
    - Lowered contract processing time by several hours

    Register now to learn how Outbrain utilized DocuSign to improve the efficiency and effectiveness of their sales operations.
  • Discover Growth Opportunities in the Point-of-care Testing Area Discover Growth Opportunities in the Point-of-care Testing Area Divyaa Ravishankar, Paul Pickering, CEO, Ubiquitome, Herbert Torfs, VP Business Development and Strategy, GenePOC Sep 7 2016 4:00 pm UTC 60 mins
    This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the point-of-care testing industry. We will also be joined by Paul Pickering, president and CEO, Ubiquitome, and Herbert Torfs, VP Business Development and Strategy, GenePOC, who will discuss their experience with market trends, regulatory road blocks, and unaddressed needs in the US, Europe, and developing and underdeveloped nations.
  • Measuring the cost of the right interventions in diabetes Measuring the cost of the right interventions in diabetes John Grumitt, IDF/Diabetes UK, Prof Michael Trenell, Newcastle University, Dr Phil McEwan Sep 8 2016 2:00 pm UTC 75 mins
    Diabetes is one of the most prevalent and most costly conditions worldwide – with a prevalence equating to 8.5% of the global population. Due to the complex nature of diabetes, with numerous co-morbidities and its asymptomatic nature, accurately modelling and therefore discerning which interventions are most effective, in terms of cost and patient impact is an equally complicated process.

    This webinar will explore the patient pathway and how effective modelling – when pharma works together with healthcare stakeholders – can improve outcomes for both patients and the healthcare system as a whole.
  • Transforming brain radiosurgery: clinical application of a novel tool Transforming brain radiosurgery: clinical application of a novel tool Dr Dheerendra Prasad MD, MCh, FACRO, medical director, radiation medicine, Roswell Park Cancer Institute, Buffalo, New York Sep 9 2016 3:00 pm UTC 60 mins
    Medical doctor Dheerandra Prasad talks about clinical prospects and his clinical experience of the Leksell Gamma Knife® Icon™ for precise, frameless and frame-based stereotactic radiosurgery of the brain.

    Leksell Gamma Knife Icon combines the unprecedented accuracy of Gamma Knife with integrated immobilization, workflow and imaging technologies to provide even greater clinical flexibility for brain radiosurgery. This is due to a number of advancements, including on-board cone beam computer tomography, a thermoplastic mask system and an infrared-based high-definition motion-management system for patient tracking during treatment, which provide the opportunity to perform frameless and fractionated radiosurgery, as well as frame-based and single-session treatments, and to perform online adaptive planning.

    Based on his experience as a radiation oncologist and a neurosurgeon, Dr Prasad discusses how these novel features of Gamma Knife Icon have opened up the possibility of extending Gamma Knife treatment to more patients and new indications. He will explain how the on-board CBCT imaging capabilities of Gamma Knife Icon have improved imaging workflows for both frame-based and frameless treatments at his clinic, and how the thermoplastic mask system has enabled him to treat targets outside the range of frame fixation. He also will describe how the ability to fractionate treatments has allowed him to expand his case mix, for example to patients with tumours that are situated close to critical structures, allowing such patients to benefit from the superior dosimetry of Gamma Knife.

    Drawing from individual case studies and his personal experience, Dr Prasad will illustrate how Leksell Gamma Knife Icon is a valuable and flexible tool for brain radiosurgery and its role alongside linac-based stereotactic radiotherapy in today’s radiation oncology centres.
  • 60 years of the medical physics revolution 60 years of the medical physics revolution Steven Meikle, Ph.D. Professor of Medical Imaging Physics The University of Sydney, Australia Sep 13 2016 2:00 pm UTC 45 mins
    In the first in a series of webinars showcasing presentations from the PMB 60th Anniversary Symposium, Steven Meikle will examine the progression of medical physics over the last 60 years. He will discuss key developments in radiation therapy, cancer diagnosis and surgery, and describe some of the underlying technologies that enabled this medical physics revolution.
  • Getting closer to your customer through video technology Getting closer to your customer through video technology Damian Eade, Tim Williams, Andrew McConaghie Sep 14 2016 2:00 pm UTC 75 mins
    Video content accounted for 64% of all the world’s internet traffic in 2014 and is expected to grow to 80% by 2019. As the way in which we connect and digest information evolves, high quality mobile video capture and advanced digital analysis offers ever more authentic, intimate and rich insights into the customers’ world. This webinar will focus on:
    – How emerging technology can enable us to realise the true value of ‘video data’ in our analysis and beyond
    – How mobile technology can be used to get you closer to your customers and their real world experiences right from the earliest stages in product development
    – How real world video content can engage your key stakeholders and ensure customer insights drive action
  • Strengthening market access deliverables by harnessing the patient journey Strengthening market access deliverables by harnessing the patient journey Dominic Tyer Sep 14 2016 2:00 pm UTC 60 mins
    In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.

    The patient journey can be at the centre of this drive by shaping an aligned communication on ‘value’.

    On 14 September Executive Insight, in association with PMGroup, will host a free webinar about how to leverage the patient journey to strengthen market access deliverables.

    It will investigate how to develop a common value story, what such a framework should look like and the role of cross-functional working when it comes to putting these ideas into practice.
  • Genome Pricing Milestone Warrants New Strategic Positions for Service Providers Genome Pricing Milestone Warrants New Strategic Positions for Service Providers Christi Bird, Senior Industry Analyst Sep 15 2016 3:00 pm UTC 60 mins
    Frost & Sullivan predicts the $100 genome will be achieved by 2024 should new technology launches continue at the current pace. This milestone will disrupt the services space both positively and negatively, as some customers will opt to bring sequencing in-house at that price point, while others that continue to outsource will greatly expand their large-scale sequencing projects. A new business model of answer-based sequencing services is likely to emerge in 10 years.
  • Publishing Secrets for Early Career Researchers in Nursing Publishing Secrets for Early Career Researchers in Nursing Professor Roger Watson; Charon A. Pierson; Susan Gennaro; Bernadette Mazurek Melnyk; Elizabeth Park Sep 20 2016 1:30 pm UTC 60 mins
    Demystify the process of writing and submitting your research with practical tips on selecting the right journal, handling feedback, bouncing back from rejection and streamlining the writing process.
    Wiley Author Services presents Publishing Secrets for Early Career Researchers in Nursing. If you’re new to research or want to know more about the process, this webinar will give you practical guidance on:
    •Selecting the RIGHT Journal
    •Preparing your article – How to follow author guidelines
    •Peer Review/Rejection – How to address reviewers comments
    •Post publication and SEO – How to promote your work
    With expert advice from top editors in the nursing research community you’ll discover all you need to help you successfully publish your next article.

    Speakers include:

    Susan Gennaro, RN, PhD, FAAN
    Dean and Professor, Boston College
    Editor-in-Chief of Journal of Nursing Scholarship

    Bernadette Mazurek Melnyk, PhD, RN, CPNP/PMHNP, FAANP, FNAP, FAAN
    Dean, Associate Vice President for Health Promotion, Chief Wellness Officer, Ohio State University
    Editor-in-Chief of Worldviews on Evidence-Based Nursing

    Charon A. Pierson, PhD, GNP, FAANP, FAAN
    Editor-in-Chief
    Journal of the American Association of Nurse Practitioners

    Professor Roger Watson,University of Hull
    Faculty of Health and Social Care
    BSc, PhD, RN, FRSB, FFNMRCSI, FRSA, FHEA, FEANS, FRCP Edin, FRCN, FAAN
    Editor-in-Chief of Journal of Advanced Nursing

    Elizabeth Park, Wiley
  • Improve lymphocytosis management for hematopathology patients Improve lymphocytosis management for hematopathology patients Dr. Mikael Roussel Sep 21 2016 2:00 pm UTC 60 mins
    Dr. Mikael Roussel from the University Hospital of Rennes, France, will lead a discussion around the organization of the cell morphology and flow cytometry core laboratory. Hear his tips using Beckman Coulter's hematology solutions to improve management of patients with lymphocytosis. P.A.C.E. credit is available for your participation.*
  • Quantitative Image Analysis and Emerging Applications on the ImageStream Quantitative Image Analysis and Emerging Applications on the ImageStream Brian Hall, Senior Scientist at Millipore Sigma Sep 21 2016 4:00 pm UTC 75 mins
    The ImageStream is a multispectral imaging flow cytometer that generates high resolution images of cells at a rate of 1000’s of cells per second. This allows for the rapid acquisition of tens of thousands of images per sample. Using the IDEAS image analysis software, the system calculates features based not only on fluorescence intensity but the morphology of that fluorescence as well. With this novel approach the ImageStream is able to seamlessly combine the quantitative power of flow cytometry with the high content information associated with microscopy. The system can collect data on a wide range of applications including nuclear localization during a signal transduction cascade, measuring colocalization of two probes, or quantify features on the phagocytosed particles in macrophages.
  • Unlocking the mysteries of the formation of our solar system with CHIMERA Unlocking the mysteries of the formation of our solar system with CHIMERA Prof. Gregg Hallinan – assistant professor of astronomy, Caltech Dr Colin Coates – product manager OEM & research, Andor Tech Sep 22 2016 3:00 pm UTC 60 mins
    During this webinar we will discuss the development of the Caltech High-Speed Multi-Color Camera (CHIMERA), using two Andor iXon Ultra 888 EMCCDs, for ground-based searches for occultations of sub-kilometre-sized KBOs, which it achieves through monitoring thousands of stars simultaneously.

    CHIMERA has completed 20 nights of observing in 2015 and 2016, with an additional 50 nights observing to be completed by July 2018, yielding a final data set likely to have more than 100 occultation events.

    For several years, professional astronomers have been looking to Andor as a source of extreme performance, exceptionally robust off-the-shelf detector solutions, utilized across many of the key observation sites worldwide. We will provide an overview of the key high-sensitivity, high-temporal-resolution detector technology types, used in diverse applications such as adaptive optics wavefront sensing, solar exploration, high-time-resolution astrophysics, transit exoplanet discovery, gravitational lensing and even customized guide cameras.
  • Introduction to Publishing for Early Career Researchers Introduction to Publishing for Early Career Researchers Dr. Matteo Cavalleri, Editor-In-Chief and Martin Wells, Journals Editor, Journals Publishing Manager Sep 28 2016 1:00 pm UTC 45 mins
    Are you new to publishing your research? Struggling to select a journal or understand Peer Review? In this webinar you’ll hear practical tips from top journal editors who’ll guide you through the publishing process and help you discover all you need to know to successfully publish your next article.
    You’ll learn more about:
    •Where to start if you’re thinking of publishing your research
    •Selecting the right journal
    •Writing and submitting your article
    •Peer Review
    •Publishing Ethics
    •Tools to help you through publication and beyond
    Plus you’ll have the chance to ask the editors your questions and connect with fellow researchers attending from across the globe. Sign up today to reserve your place!
  • Pediatric Cancer and IHC Pediatric Cancer and IHC Jeff Gordon, Director of OEM Sales, Cell Marque Corporation Sep 28 2016 5:00 pm UTC 75 mins
    Childhood cancer and pediatric cancer are general terms used to describe a wide range of neoplasms found in children and teenagers. Occurring in approximately 1 in 300 people under the age of 20, compared to 1 in 6 adults, pediatric cancers are more rare than adult cancers. Because less is known about pediatric cancers, diagnosis can be quite challenging for pathologists.

    This presentation covers the basic science, as well as facts and statistics about pediatric cancer. We will discuss how the utility of immunohistochemical testing along with the application of novel antibodies can contribute to accurate diagnosis and survival rates of pediatric cancer patients.
  • Challenges and Successes in Externalization of the ADC Supply Chain Challenges and Successes in Externalization of the ADC Supply Chain Firelli Alonso, Ph.D. Nov 3 2016 2:00 pm UTC 75 mins
    Sourcing for the manufacture and control of Antibody-Drug Conjugates (ADCs) used in clinical trials requires strategic planning, establishment of a specialized support network, and execution of several interdependent tasks. ADCs are complex molecules, a fusion of a biological, the monoclonal antibody (mAb), and of small molecules, the linker and the toxic payload. Facilities of acceptable standards for the handling of high potency materials need to be engaged, and there is a limited supply currently. This is further complicated by the fact that there is not one contract facility that has fully integrated services, a “one-stop shop” capable of mAb production, linker and/or payload synthesis, conjugation of mAb to linker-payload to make the Drug Substance, and finally, formulation of the ADC to make the Drug Product. Strategizing the best outsourcing practices for producing and testing ADCs, and establishing guiding principles for externalization to ensure the selection of the right CMOs for ADC outsourcing and technology transfer, will be further discussed.
  • Subvisible Particle Identification & Characterisation by Multi-Technique Methods Subvisible Particle Identification & Characterisation by Multi-Technique Methods Dr Jonas Hoeg Thygesen Nov 10 2016 2:00 pm UTC 75 mins
    Observable foreign and particulate matter has for a long time been recognized as a critical quality attribute for production of injectable protein formulations. Recently, a focus shift towards these particles and even smaller particles (particulate matter or subvisible particles) has been seen from the pharmaceutical industry, academia and the different regulatory bodies. Two of the central documents in this context are:

    1. The FDA Guidance for Industry on Immunogenicity Assessment for Therapeutic Protein Products1 and

    2. United States Pharmacopia Chapter 2
  • Continuous Bioprocessing: PAT for Process Monitoring & Control to enable RPR Continuous Bioprocessing: PAT for Process Monitoring & Control to enable RPR Jeff Doyle Nov 15 2016 3:00 pm UTC 75 mins
    Continuous bioprocessing offers potential to enhance productivity and product quality uniformity while simultaneously decreasing facility footprint and associated operational overhead. Advances in technology and increasing commercial pressures are leading to an increased interest in continuous processing across the biopharmaceutical sector. A number of companies are exploring and advancing continuous bioprocessing and this presents a range of opportunity and challenges, including the use of Process Analytical Technology (PAT) for process characterization, process control, and process robustness, in support of a Rapid Product Release (RPR) strategy.
  • Implementing Single-Use PAT at seed stage to simplify cell culture operations Implementing Single-Use PAT at seed stage to simplify cell culture operations Dr Jose R. Vallejos Jan 18 2017 3:00 pm UTC 75 mins
    Single-Use Process Analytical Technologies (PAT) tools have a great potential to not only increase process understanding at the seed stage but also simplify cell culture operations. By utilizing PAT, the risk from bioburden or contamination can be significantly reduced and the overall operating efficiency increased. In fact, PAT also provides a data-driven platform to integrate Process Development and Manufacturing Operations that can mitigate risks associated with technology/process transfer.